Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.49m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Capacity Value Update

15 Nov 2024 07:00

RNS Number : 3337M
Helios Underwriting Plc
15 November 2024
 

 

 

15 November 2024

 

Helios Underwriting plc

 ("Helios" or the "Company")

Capacity Value Update

 

Helios Underwriting ('Helios' or the 'Company'), the only publicly traded company offering access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, today announces an update on the value of Company's capacity portfolio following the Capacity Auctions at Lloyd's.

 

Michael Wade, Chairman of Helios, commented:

 

"The Freehold Capacity Portfolio has continued to deliver value to shareholders and we have  realised £14m of capacity value to increase the tangible assets of the Company. An increase in the Net Asset Value per share of 15p (2023 - 18p) to 206p is expected , representing an increase of 8% over the reported NAV as at 30th June 2024, and this demonstrates the strength of our portfolio."

 

Capacity Value

The value of the capacity fund expected as at 31st December 2024 using the weighted average prices of capacity from the 2024 Lloyd's capacity auctions is expected to decrease to £75m (31 December 2023: £82.4m) having realised £14m of cash from some of syndicates within the portfolio.

 

The analysis of the changes to the Freehold Capacity in the portfolio is as follows:

 

Freehold Capacity

Value of Capacity

Value per £ capacity

 

£m

£m

 

Capacity Portfolio at 31 Dec 2023

175.9

82.4

0.47

Pre-emption capacity

15.6

3.4

Mid-year support

5.0

-

Disposal of capacity at capacity auctions

-37.8

-13.9

Increase / Acquisition of Freehold capacity

10.8

0.1

Increase in portfolio value

2.9

Capacity Portfolio expected at 31 Dec 2024

166.4

74.9

0.45

 

A summary of the movements in capacity and its value as follows:

 

The syndicates supported by Helios offered free capacity of £15.6m (2023 - £14.7m) by way of pre-emptions to support the improved underwriting market. The value of the pre-emptions taken up have increased the value of the portfolio by £3.4m (2023 £7.0m).

 

Helios supported the Fidelis Syndicate (syndicate 3123), which commenced business in July 2024 and will allocate £13m of capacity for the 2025 year of account to this syndicate. The weighted average price for this syndicate was 28p per £ of capacity in the recent auctions.

 

The average price per £ of capacity with value after the 2024 Auctions was 45p (2022 - 47p) reflecting a small decrease in auction prices and change in the mix of the freehold portfolio. 

 

Impact on Net Asset Value as 30th June 2024

Total

Net Assets

 

£m

per Share - £

 

Opening at 30th June 2024

140.7

1.91

Pre-emption capacity

3.4

Net profit on disposal of syndicate capacity

1.8

Increase in portfolio value

2.9

8.1

Corporation Tax provision

-2.0

Pro-forma Net Asset Value

146.8

2.06

Number of shares in Issue

71.3

 

 

The sale of £38m of capacity on the auctions resulted in a small profit of £1.8m from the value held on the balance sheet. It has increased both the cash available and the Tangible Net Assets by £14m and has reduced the exposure in the balance sheet to the value of the capacity.

 

Following the 2024 Auctions and taking into account the further buy back of shares by the Company in July, the proforma Net Asset per share as 30th June 2024 is expected to increase by 8% to 206p

 

The Company expects to publish its updated Net Asset Value as at 30 September 2024 per share in early December 2024.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) NO 596/2014.

ENDS

For further information, please contact:

Helios Underwriting plc

Michael Wade - Chairman

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

Ed Berry / Tom O'Brien

heliosunderwriting@fticonsulting.com

+44 (0)7703 330 199 / +44 (0)7929 021 492

 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £512m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQKQBQOBDDNDD
Date   Source Headline
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20221:13 pmRNSResult of AGM
1st Jun 20222:31 pmRNSPosting of Annual Report and Notice of AGM
27th May 20227:00 amRNSFinal Results
23rd May 20229:10 amRNSQuarterly Syndicate Mid Point Forecasts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.